These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
263 related articles for article (PubMed ID: 36244446)
1. Sesamol inhibits proliferation, migration and invasion of triple negative breast cancer via inactivating Wnt/β-catenin signaling. Ma X; Hu X; Zhu Y; Jin H; Hu G; Ding L; Ning S Biochem Pharmacol; 2022 Dec; 206():115299. PubMed ID: 36244446 [TBL] [Abstract][Full Text] [Related]
2. Shikonin inhibits triple-negative breast cancer-cell metastasis by reversing the epithelial-to-mesenchymal transition via glycogen synthase kinase 3β-regulated suppression of β-catenin signaling. Chen Y; Chen ZY; Chen L; Zhang JY; Fu LY; Tao L; Zhang Y; Hu XX; Shen XC Biochem Pharmacol; 2019 Aug; 166():33-45. PubMed ID: 31071331 [TBL] [Abstract][Full Text] [Related]
3. The natural compound Jatrophone interferes with Wnt/β-catenin signaling and inhibits proliferation and EMT in human triple-negative breast cancer. Fatima I; El-Ayachi I; Taotao L; Lillo MA; Krutilina RI; Seagroves TN; Radaszkiewicz TW; Hutnan M; Bryja V; Krum SA; Rivas F; Miranda-Carboni GA PLoS One; 2017; 12(12):e0189864. PubMed ID: 29281678 [TBL] [Abstract][Full Text] [Related]
4. miR-221/222 activate the Wnt/β-catenin signaling to promote triple-negative breast cancer. Liu S; Wang Z; Liu Z; Shi S; Zhang Z; Zhang J; Lin H J Mol Cell Biol; 2018 Aug; 10(4):302-315. PubMed ID: 30053090 [TBL] [Abstract][Full Text] [Related]
5. Inhibition of endoplasmic reticulum stress alleviates triple-negative breast cancer cell viability, migration, and invasion by Syntenin/SOX4/Wnt/β-catenin pathway via regulation of heat shock protein A4. Nan J; Hu X; Guo B; Xu M; Yao Y Bioengineered; 2022 Apr; 13(4):10564-10577. PubMed ID: 35442158 [TBL] [Abstract][Full Text] [Related]
6. Cardamonin, a chalcone, inhibits human triple negative breast cancer cell invasiveness by downregulation of Wnt/β-catenin signaling cascades and reversal of epithelial-mesenchymal transition. Shrivastava S; Jeengar MK; Thummuri D; Koval A; Katanaev VL; Marepally S; Naidu VGM Biofactors; 2017 Mar; 43(2):152-169. PubMed ID: 27580587 [TBL] [Abstract][Full Text] [Related]
7. Upregulation of collagen type X alpha 1 promotes the progress of triple-negative breast cancer via Wnt/β-catenin signaling. Peng J; Liu X; Mao Y; Lv M; Ma T; Liu J; Zhou Q; Han Y; Li X; Wang H Mol Carcinog; 2024 Aug; 63(8):1588-1598. PubMed ID: 38780151 [TBL] [Abstract][Full Text] [Related]
8. CUL4B promotes metastasis and proliferation in pancreatic cancer cells by inducing epithelial-mesenchymal transition via the Wnt/β-catenin signaling pathway. He YM; Xiao YS; Wei L; Zhang JQ; Peng CH J Cell Biochem; 2018 Jul; 119(7):5308-5323. PubMed ID: 29274277 [TBL] [Abstract][Full Text] [Related]
9. A novel humanized Frizzled-7-targeting antibody enhances antitumor effects of Bevacizumab against triple-negative breast cancer via blocking Wnt/β-catenin signaling pathway. Xie W; Zhao H; Wang F; Wang Y; He Y; Wang T; Zhang K; Yang H; Zhou Z; Shi H; Wang J; Huang G J Exp Clin Cancer Res; 2021 Jan; 40(1):30. PubMed ID: 33436039 [TBL] [Abstract][Full Text] [Related]
10. FL118, a novel camptothecin analogue, suppressed migration and invasion of human breast cancer cells by inhibiting epithelial-mesenchymal transition via the Wnt/β-catenin signaling pathway. Yang Z; Ji L; Jiang G; Liu R; Liu Z; Yang Y; Ma Q; Zhao H Biosci Trends; 2018; 12(1):40-46. PubMed ID: 29553100 [TBL] [Abstract][Full Text] [Related]
11. Single-cell transcriptomics reveals the intra-tumoral heterogeneity and SQSTM1/P62 and Wnt/β-catenin mediated epithelial to mesenchymal transition and stemness of triple-negative breast cancer. Shome R; Sen P; Sarkar S; Ghosh SS Exp Cell Res; 2024 May; 438(1):114032. PubMed ID: 38583856 [TBL] [Abstract][Full Text] [Related]
12. MicroRNA-590-5p functions as a tumor suppressor in breast cancer conferring inhibitory effects on cell migration, invasion, and epithelial-mesenchymal transition by downregulating the Wnt-β-catenin signaling pathway. Gao J; Yu SR; Yuan Y; Zhang LL; Lu JW; Feng JF; Hu SN J Cell Physiol; 2019 Feb; 234(2):1827-1841. PubMed ID: 30191949 [TBL] [Abstract][Full Text] [Related]
13. Wnt signaling blockage inhibits cell proliferation and migration, and induces apoptosis in triple-negative breast cancer cells. Bilir B; Kucuk O; Moreno CS J Transl Med; 2013 Nov; 11():280. PubMed ID: 24188694 [TBL] [Abstract][Full Text] [Related]
14. Hydroxytyrosol inhibits cancer stem cells and the metastatic capacity of triple-negative breast cancer cell lines by the simultaneous targeting of epithelial-to-mesenchymal transition, Wnt/β-catenin and TGFβ signaling pathways. Cruz-Lozano M; González-González A; Marchal JA; Muñoz-Muela E; Molina MP; Cara FE; Brown AM; García-Rivas G; Hernández-Brenes C; Lorente JA; Sanchez-Rovira P; Chang JC; Granados-Principal S Eur J Nutr; 2019 Dec; 58(8):3207-3219. PubMed ID: 30460610 [TBL] [Abstract][Full Text] [Related]
15. MAGE-A is frequently expressed in triple negative breast cancer and associated with epithelial-mesenchymal transition. Wang H; Sang M; Geng C; Liu F; Gu L; Shan B Neoplasma; 2016; 63(1):44-56. PubMed ID: 26639233 [TBL] [Abstract][Full Text] [Related]
16. Tweaking EMT and MDR dynamics to constrain triple-negative breast cancer invasiveness by EGFR and Wnt/β-catenin signaling regulation. Shome R; Ghosh SS Cell Oncol (Dordr); 2021 Apr; 44(2):405-422. PubMed ID: 33398673 [TBL] [Abstract][Full Text] [Related]
17. Antrodia camphorata inhibits epithelial-to-mesenchymal transition by targeting multiple pathways in triple-negative breast cancers. Hseu YC; Chang GR; Pan JY; Rajendran P; Mathew DC; Li ML; Liao JW; Chen WT; Yang HL J Cell Physiol; 2019 Apr; 234(4):4125-4139. PubMed ID: 30146779 [TBL] [Abstract][Full Text] [Related]
18. H3K27ac-induced RHOXF2 activates Wnt2/β-catenin pathway by binding to HOXC13 to aggravate the malignant progression of triple negative breast cancer. Guo M; Wang R; Nie M; Zhang H; Wang C; Song C; Niu S Cell Signal; 2024 Aug; 120():111196. PubMed ID: 38697448 [TBL] [Abstract][Full Text] [Related]
19. RNF43 Suppressed Triple-Negative Breast Cancer Progression by Inhibiting Wnt/beta-Catenin Pathway. Zhu L; Shi H; Li P; Zhang P Ann Clin Lab Sci; 2023 Jan; 53(1):21-29. PubMed ID: 36889779 [TBL] [Abstract][Full Text] [Related]
20. AQP5 promotes epithelial-mesenchymal transition and tumor growth through activating the Wnt/β-catenin pathway in triple-negative breast cancer. Zhu Z; Li T; Wang H; Jiao L Mutat Res; 2024 Jun; 829():111868. PubMed ID: 38959561 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]